G8R-20129-07875
4 vaccinations
1 coded response
47 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 405 / KY
- Registered
- 2021-08-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
5FH-59419-49801
Child or adolescent in my care · Male · 2021-11-11
E97-30502-88111
Child or adolescent in my care · Male · 2022-07-26
Timeline
-
2021-08-15
Registered in v-safe
-
2021-08-15
Dose 1 — Pfizer-BioNTech
- 2021-08-15
-
2021-08-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Nausea, Abdominal painAdult check-in
- 2021-08-17
-
2021-08-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-08-19
-
2021-08-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-08-21
- 2021-08-22
- 2021-08-29
-
2021-09-05
Dose 2 — Pfizer-BioNTech
-
2021-09-05
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-09-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-09
- 2021-09-10
- 2021-09-11
- 2021-09-12
- 2021-09-19
- 2021-09-26
- 2021-10-03
- 2021-10-10
- 2021-10-17
- 2021-12-05
-
2022-02-25
Dose 3 — Pfizer-BioNTech
- 2022-03-06
- 2022-03-06
- 2022-03-11
- 2022-03-18
- 2022-03-25
- 2022-04-01
- 2022-04-08
- 2022-05-27
- 2022-08-28
-
2022-10-10
Dose 4 — Pfizer-BioNTech
-
2022-10-10
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2022-10-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-12
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-19
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-14
-
2022-11-21
Survey response — day 42, dose 4MedDRA: Arthralgia — Feeling: GoodFree text: Joint painMedDRA releases: 2024-11 · check-in free text available
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-15 | Pfizer-BioNTech | No |
| 2 | 2021-09-05 | Pfizer-BioNTech | No |
| 3 | 2022-02-25 | Pfizer-BioNTech | No |
| 4 | 2022-10-10 | Pfizer-BioNTech | No |
Free text
Release 12 — day 42, dose 4
Symptoms: Joint pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release